EU conference 'The Microbial Threat'

International Journal of Antimicrobial Agents

Volumn 11, Issue 2, 1999, Pages 101-105

  Mevius, D J ^a   Sprenger, M J W ^b   Wegener, H C ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Antibiotics; Antimicrobial resistance; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC RESISTANCE; DISEASE TRANSMISSION; DRUG USE; EUROPE; FINANCIAL MANAGEMENT; HUMAN; MEDICAL RESEARCH; MONITORING; NONHUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033004086     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00093-4     Document Type: Review

References (23)

1. Arason VA, Kristinsson KG, Sigurdsson JA, Stefánsdóttir G, Mölstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Br Med J 1996;313:387-91.
2. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of β-lactam. J Am Med Assoc 1998;279:365-70.
3. Swartz MN. Use of antimicrobial agents and drug resistance. New Engl J Med 1997;337:491-2.
4. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angelo FJ. Emergence of multi drugresistant Salmonella enterica serotype typhimurium DT104 infections in the United States. New Engl J Med 1998;338:1333-8.
5. Flaherty JP, Weinstein RA. Nosocomial infection caused by antibiotic resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol 1996;17:236-48.
6. Gold HS, Moellering RC. Antimibrobial-drug resistance. New Engl J Med 1996;335:1443-5.
7. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Sciene 1992;257:1050-5.
8. Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistent Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-5.
9. Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663-70.
10. Klastersy J, Glauser MP, Schimpff SC, Zinner SH, Gaya H and the European Organization for Research on Treatment of Cancer Antimicrobial Therapy Project Group. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob. Agents Chemother. 1986;29:263-270.
11. Wain J, Hoa NTT, Chinh NT, Vinh H, Everett MJ, Diep TS, et al. Quinolone-resistant Salmonella typhi in Vietnam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997;25:1404-10.
12. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New Engl J Med 1997;337:441-6.
13. Endtz HP, Ruys GJ, Klingeren B van, et al. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of quinolones in veterinary medicine. J Antimicrob Chemothr 1991;31:1197-9.
14. Wegener HC, Aarestrup FM, Jensen LB, Hammerum AM, Bager F. The association between the use of antimicrobial growth promoters and the developmenet of resistance in pathogenic bacteria towards growth promoting and therapeutic antimicrobials. J Anim Feed Sci 1998;7:7-14.
15. Hummel R, Tschäpe H, Witte W. Spread of plasmid-mediated nourseothricin resistance due to antibiotic use in animal husbandry. J Basic Microbiol 1986;26:461-6.
16. Tschäpe H, Tietze E, Prager R, et al. Plasmid born streptothricin resistance in gram-negative bacteria. Plasmid 1984;12:189-96.
17. DANMAP. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. Danmap 1997: ISSN 1397-078X.
18. Bronzwaer SLAM, Sprenger MJW. A surveillance system for Europe. Br Med J 1998;317:615.
19. Gyssens IC, Van den Broek PJ, Kullberg BJ, Hekster YA, Van der Meer JWM. Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation. J Antimicrob Chemother 1992;30:724-727
20. Gyssens IC, Blok WL, van den Broek PJ, Hekster YA, van der Meer JW. Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine. Eur J Clin Microbiol Infect Dis 1997;16:904-12.
21. Gyssens IC, Kullberg BJ. Improving the quality of antimicrobial drug use can result in cost containment. Pharm World Sci 1995;17:163-7.
22. van den Bogaard AE, Breeuwsma AJ, Julicher CH, Mostert A et al. Een veterinair antibioticumbeleid, aanbevelingen van een werkgroep. Tijdschrift voor Diergeneeskunde 1994;119:160-183.
23. Wise R. The development of new antimicrobial agents. Br Med J 1998;317:633-4.